HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoru Todo Selected Research

dehydroxymethylepoxyquinomicin

1/2013Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
3/2012A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
5/2011Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
8/2010Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.
9/2008The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoru Todo Research Topics

Disease

54Neoplasms (Cancer)
01/2019 - 04/2002
30Hepatocellular Carcinoma (Hepatoma)
01/2019 - 05/2002
15Neoplasm Metastasis (Metastasis)
04/2016 - 05/2002
11Stomach Neoplasms (Stomach Cancer)
05/2016 - 09/2003
10Inflammation (Inflammations)
03/2016 - 05/2003
9Ischemia
12/2016 - 01/2002
8Reperfusion Injury
12/2016 - 01/2002
7Carcinoma (Carcinomatosis)
05/2016 - 05/2002
7Colonic Neoplasms (Colon Cancer)
01/2016 - 05/2002
7Breast Neoplasms (Breast Cancer)
11/2006 - 01/2003
6Adenocarcinoma
01/2014 - 06/2006
5Liver Failure
05/2018 - 11/2006
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2012 - 01/2004
5Prostatic Neoplasms (Prostate Cancer)
12/2010 - 11/2006
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2013 - 02/2006
4Thrombosis (Thrombus)
08/2011 - 12/2002
4Carcinogenesis
07/2011 - 10/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2016 - 06/2007
3Liver Diseases (Liver Disease)
01/2016 - 01/2008
3Hepatitis B
06/2013 - 05/2002
3Fibrosis (Cirrhosis)
04/2013 - 05/2002
3Acute Liver Failure (Fulminant Hepatic Failure)
09/2008 - 10/2004
3Infections
05/2008 - 11/2005
3Colorectal Neoplasms (Colorectal Cancer)
09/2007 - 11/2002
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2016 - 03/2012
2Colitis
03/2016 - 03/2012
2Splenomegaly
11/2010 - 11/2005
2Pancreaticobiliary Maljunction
11/2009 - 03/2008
2Biliary Atresia
01/2009 - 11/2008
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
09/2008 - 01/2008
2Stroke (Strokes)
01/2008 - 07/2005
2Hepatitis
11/2006 - 06/2006
2End Stage Liver Disease
07/2006 - 09/2004
2Hepatitis C
06/2006 - 05/2002
2Esophageal Neoplasms (Esophageal Cancer)
05/2006 - 01/2004

Drug/Important Bio-Agent (IBA)

12Peptides (Polypeptides)IBA
01/2016 - 05/2002
10Proteins (Proteins, Gene)FDA Link
10/2015 - 09/2004
9Messenger RNA (mRNA)IBA
03/2016 - 10/2003
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2019 - 09/2004
7Fluorouracil (Carac)FDA LinkGeneric
11/2009 - 10/2003
6Pharmaceutical PreparationsIBA
05/2018 - 07/2004
6MesothelinIBA
10/2017 - 11/2011
6NF-kappa B (NF-kB)IBA
03/2012 - 09/2008
5CytokinesIBA
03/2016 - 04/2002
5dehydroxymethylepoxyquinomicinIBA
01/2013 - 09/2008
5Cisplatin (Platino)FDA LinkGeneric
04/2007 - 10/2003
4Polysaccharides (Glycans)IBA
06/2013 - 05/2007
4Biomarkers (Surrogate Marker)IBA
06/2013 - 02/2004
4Immunoglobulin G (IgG)IBA
12/2010 - 02/2004
4Epirubicin (Ellence)FDA LinkGeneric
05/2007 - 12/2004
4Macrophage Migration-Inhibitory FactorsIBA
07/2005 - 05/2003
3Phenobarbital (Luminal)FDA Link
04/2015 - 12/2012
3Transcription Factors (Transcription Factor)IBA
01/2013 - 07/2011
3Tumor Biomarkers (Tumor Markers)IBA
01/2012 - 09/2004
3Cancer VaccinesIBA
01/2012 - 09/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2016 - 04/2008
2InterleukinsIBA
03/2016 - 03/2012
2acarboxyprothrombin (PIVKA)IBA
10/2015 - 06/2012
2Fetal Proteins (Fetoprotein)IBA
10/2015 - 01/2012
2AlbuminsIBA
10/2015 - 06/2012
2Vitamin KFDA Link
10/2015 - 06/2012
2Biological ProductsIBA
01/2014 - 10/2003
2Glucose (Dextrose)FDA LinkGeneric
09/2013 - 11/2012
2DNA (Deoxyribonucleic Acid)IBA
04/2013 - 01/2009
2Streptozocin (Streptozotocin)FDA Link
11/2012 - 03/2004
2ErbB Receptors (EGF Receptor)IBA
06/2012 - 07/2004
2squamous cell carcinoma-related antigenIBA
06/2012 - 09/2006
2Therapeutic UsesIBA
03/2012 - 05/2007
2AntigensIBA
01/2012 - 05/2002
2BilirubinIBA
09/2011 - 11/2008
2HLA-A3 Antigen (HLA A3 Antigen)IBA
09/2010 - 11/2009
2HLA-A2 Antigen (HLA A2 Antigen)IBA
09/2010 - 05/2002
2Protein Subunit VaccinesIBA
09/2010 - 11/2009
2phytobacteriomycin (PBM)IBA
11/2009 - 03/2008
2Indicators and Reagents (Reagents)IBA
11/2008 - 10/2004
2Acetaminophen (Paracetamol)FDA LinkGeneric
09/2008 - 01/2008
2AntioxidantsIBA
03/2008 - 01/2008
2EdaravoneIBA
01/2008 - 07/2005
2EnzymesIBA
10/2007 - 09/2007
2HLA Antigens (Human Leukocyte Antigens)IBA
08/2007 - 11/2006
2Androgen Receptors (Androgen Receptor)IBA
08/2007 - 11/2006
2titanium silicide (TS-1)IBA
07/2007 - 04/2007
2Mitoxantrone (Novantrone)FDA LinkGeneric
05/2007 - 03/2006
2Adenosine (Adenocard)FDA LinkGeneric
05/2007 - 05/2004
2Docetaxel (Taxotere)FDA Link
11/2006 - 06/2006
2Ribavirin (Virazole)FDA LinkGeneric
06/2006 - 05/2002
2InterferonsIBA
06/2006 - 05/2002

Therapy/Procedure

25Therapeutics
05/2016 - 01/2003
20Liver Transplantation
10/2021 - 05/2002
18Hepatectomy
10/2015 - 01/2002
11Drug Therapy (Chemotherapy)
05/2011 - 12/2002
8Transplantation
09/2013 - 06/2002
6Immunotherapy
10/2017 - 05/2002
3Adjuvant Chemotherapy
11/2009 - 10/2003
3Lymph Node Excision (Lymph Node Dissection)
10/2009 - 01/2004
2Thrombectomy
10/2013 - 08/2011
2Operative Surgical Procedures
11/2012 - 10/2007
2Splenectomy
11/2010 - 11/2005
2Kidney Transplantation
09/2010 - 07/2005
2Subcutaneous Injections
09/2008 - 01/2008